TOPAMAX Safety Questions, TOPAMAX Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TOPAMAX. Our extensive database of TOPAMAX adverse events and TOPAMAX warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TOPAMAX

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




TOPAMAX Safety Reports

Total TOPAMAX reports: 754.
TOPAMAX FDA safety alerts: 2001 2003 2005 .
Reported deaths: 22    Reported hospitalizations: 172.
Take TOPAMAX Side Effects Survey or Share Your TOPAMAX Story. TOPAMAX Usage.

Showing 1-75 of 754 Next >

Physician from BRAZIL reported TOPAMAX problem on Feb 16, 2007. Female patient, 59 years of age, weighting 220.5 lb, was diagnosed with eating disorder, pain, depression, hypertension, diabetes mellitus and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fatigue, muscle contractions involuntary, tachycardia. TOPAMAX dosage: unknown. During the same period patient was treated with VENLAFAXINE, CLORANOLOL, INSULIN, RIVOTRIL, PROPRANOLOL, NIFEDIPINE. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Feb 23, 2007. Female patient, 53 years of age, weighting 100.0 lb, was diagnosed with migraine and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: anosmia. TOPAMAX dosage: 50MG BID PO. Patient recovered.

Physician from UNITED KINGDOM reported TOPAMAX problem on Feb 20, 2007. Male patient, 15 years of age, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: anaemia, lymphocytosis, neutrophil count decreased. TOPAMAX dosage: unknown. During the same period patient was treated with VALPROATE. Patient recovered.

TOPAMAX problem was reported by a Pharmacist from UNITED KINGDOM on Feb 21, 2007. Female patient, 40 years of age, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: neutropenia. TOPAMAX dosage: unknown. Patient recovered.

Health Professional from UNITED KINGDOM reported TOPAMAX problem on Feb 14, 2007. Female patient, 18 years of age, weighting 81.57 lb, was diagnosed with convulsion and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: convulsion, gastrointestinal haemorrhage, medical device complication, oesophagitis, renal failure, sepsis, treatment noncompliance. TOPAMAX dosage: unknown. During the same period patient was treated with PHENYTOIN, LEVETORAZEPAM, VALPROATE, SEDATIVES, NORADRENALIN. Patient died.

TOPAMAX problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Female patient, weighting 150.0 lb, was diagnosed with migraine prophylaxis, urinary tract infection and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia. TOPAMAX dosage: unknown. During the same period patient was treated with CIPRO. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TOPAMAX problem on Mar 01, 2007. Female patient, 48 years of age, was diagnosed with migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: eye pain, neuroleptic malignant syndrome, paraesthesia. TOPAMAX dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, RELPAX, NASONEX, ZYRTEC. Patient recovered.

TOPAMAX problem was reported by a Pharmacist from UNITED STATES on Feb 22, 2007. Female patient was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: dysarthria. TOPAMAX dosage: unknown. During the same period patient was treated with SEROQUEL. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported TOPAMAX problem on Feb 23, 2007. Female patient, weighting 158.7 lb, was diagnosed with epilepsy, acute respiratory distress syndrome and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: antepartum haemorrhage, caesarean section, threatened labour. TOPAMAX dosage: unknown. During the same period patient was treated with CELESTON. Patient was hospitalized. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2007. Female patient, 43 years of age, weighting 110.0 lb, was diagnosed with migraine prophylaxis, nutritional support, pain, depression, muscle spasms and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: alopecia, arrhythmia, asthenia, dry mouth, dyspnoea. TOPAMAX dosage: unknown. During the same period patient was treated with FIORICET, CYMBALTA, FLEXERIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Mar 05, 2007. Female patient, 41 years of age, was diagnosed with migraine prophylaxis, depression, hypertension, headache and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: alopecia, chest pain, migraine, palpitations. TOPAMAX dosage: unknown. During the same period patient was treated with ROZEREM, WELLBUTRIN, LOTREL, FIORICET. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient, weighting 140.0 lb, was diagnosed with migraine prophylaxis, blood cholesterol increased and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: joint swelling, urticaria. TOPAMAX dosage: unknown. During the same period patient was treated with LIPITOR. Patient recovered.

Health Professional from UNITED KINGDOM reported TOPAMAX problem on Feb 26, 2007. Female patient, weighting 7.08 lb, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: hip dysplasia. TOPAMAX dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, CLOBAZAM, KEPPRA. Patient recovered.

TOPAMAX problem was reported by a Physician from BRAZIL on Feb 28, 2007. Female patient, weighting 7.28 lb, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: jaundice. TOPAMAX dosage: unknown. Patient recovered.

Physician from GERMANY reported TOPAMAX problem on Feb 27, 2007. Female patient, weighting 132.3 lb, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, acidosis, affect lability, aggression, exercise tolerance decreased, paraesthesia, sweat chloride test abnormal. TOPAMAX dosage: unknown. During the same period patient was treated with KEPPRA. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED KINGDOM on Feb 28, 2007. Male patient, weighting 66.14 lb, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: anaemia, lymphocytosis, neutrophil count decreased. TOPAMAX dosage: unknown. During the same period patient was treated with VALPROATE. Patient recovered.

Pharmacist from UNITED STATES reported TOPAMAX problem on Mar 07, 2007. Male patient, 52 years of age, weighting 176.4 lb, was diagnosed with convulsion and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, transaminases increased. TOPAMAX dosage: 200MG BID PO. During the same period patient was treated with PROTONIX, LANSOPRAZOLE, KEPPRA. Patient was hospitalized. Patient recovered.

TOPAMAX problem was reported by a Physician from GERMANY on Mar 02, 2007. Male patient, weighting 125.7 lb, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: hyperthyroidism. TOPAMAX dosage: unknown. During the same period patient was treated with LUMINAL. Patient recovered.

Physician from UNITED STATES reported TOPAMAX problem on Mar 02, 2007. Female patient, 42 years of age, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased. TOPAMAX dosage: unknown. Patient died.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Male patient, weighting 300.0 lb, was diagnosed with complex regional pain syndrome, muscle spasms, sleep disorder, anxiety and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: amnesia, anhidrosis, autonomic nervous system imbalance, body temperature increased, confusional state, convulsion, eye disorder, feeling jittery, headache. TOPAMAX dosage: unknown. During the same period patient was treated with ASPIRIN, VITAMIN CAP, VICODIN, VALIUM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Mar 02, 2007. Female patient, 41 years of age, weighting 135.0 lb, was diagnosed with migraine prophylaxis, cystitis interstitial, depression and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state, dizziness, dyspepsia, eructation, fall, flank pain, loss of consciousness, oedema peripheral. TOPAMAX dosage: unknown. During the same period patient was treated with ELMIRON, CYMBALTA, LEXAPRO, WELLBUTRIN, VESICARE. Patient recovered.

TOPAMAX problem was reported by a Physician from BRAZIL on Mar 09, 2007. Female patient, 59 years of age, weighting 220.5 lb, was diagnosed with eating disorder, pain, depression, diabetes mellitus, hypertension and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fatigue, muscle contractions involuntary, tachycardia. TOPAMAX dosage: unknown. During the same period patient was treated with VENLAFAXINE, INSULIN, RIVOTRIL, PROPRANOLOL, NIFEDIPINE, ENALAPRIL MALEATE. Patient recovered.

Physician from UNITED STATES reported TOPAMAX problem on Mar 06, 2007. Male patient, weighting 202.0 lb, was diagnosed with complex regional pain syndrome and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage, nephrolithiasis, retinal vein occlusion. TOPAMAX dosage: unknown. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Mar 07, 2007. Female patient, weighting 132.0 lb, was diagnosed with migraine, migraine prophylaxis, nausea and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: arrhythmia, heart rate irregular, migraine, palpitations, ventricular extrasystoles. TOPAMAX dosage: unknown. During the same period patient was treated with MAXALT, REGLAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Mar 12, 2007. Male patient, 37 years of age, weighting 220.0 lb, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: aggression, amnesia, autonomic nervous system imbalance, burning sensation, cognitive disorder, convulsion, mental impairment, overdose, sleep disorder. TOPAMAX dosage: 100 MG 1- BEDTIME 1ST WEEK; 2 X -2ND WEEK; 3X DAY 3RD WEEK. Patient was hospitalized and became disabled. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Female patient, 61 years of age, was diagnosed with convulsion prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: hospitalisation. TOPAMAX dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported TOPAMAX problem on Mar 07, 2007. Female patient, child 6 years of age, was diagnosed with convulsion and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: cataract. TOPAMAX dosage: unknown. During the same period patient was treated with LAMICTAL. Patient recovered.

TOPAMAX problem was reported by a Physician from ITALY on Mar 06, 2007. Male patient, 27 years of age, was diagnosed with grand mal convulsion and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. TOPAMAX dosage: unknown. Patient recovered.

Physician from MEXICO reported TOPAMAX problem on Mar 06, 2007. Male patient, child 10 years of age, weighting 44.09 lb, was diagnosed with epilepsy, convulsion and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: renal disorder. TOPAMAX dosage: unknown. During the same period patient was treated with TRILEPTAL, CLOBAZAM, DIPHENYLHYDANTOIN, CLONAZEPAM. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Female patient, weighting 163.0 lb, was diagnosed with weight decreased, depression, sleep disorder, pain and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: anorexia, diabetic neuropathy, diarrhoea, dysgeusia, hypoaesthesia, nausea, pain in extremity, weight increased. TOPAMAX dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, LITHIUM CARBONATE, SONATA, LAMICTAL, CYMBALTA, XANAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Mar 15, 2007. Male patient, child 12 years of age, weighting 105.0 lb, was diagnosed with convulsion and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, memory impairment, speech disorder, thinking abnormal. TOPAMAX dosage: unknown. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Mar 12, 2007. Female patient, weighting 132.0 lb, was diagnosed with migraine, migraine prophylaxis, nausea and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: arrhythmia, heart rate irregular, migraine, palpitations, ventricular extrasystoles. TOPAMAX dosage: unknown. During the same period patient was treated with MAXALT, REGLAN. Patient recovered.

Physician from NETHERLANDS reported TOPAMAX problem on Mar 08, 2007. Female patient, weighting 105.8 lb, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: aggression, amnesia, confusional state, expressive language disorder, fear, insomnia, irritability, muscle twitching, panic disorder. TOPAMAX dosage: unknown. Patient recovered.

TOPAMAX problem was reported by a Physician from ITALY on Mar 09, 2007. Female patient, 21 years of age, was diagnosed with post-traumatic epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: sinus tachycardia. TOPAMAX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported TOPAMAX problem on Mar 09, 2007. Female patient, 54 years of age, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: aggression, disorientation, feeling abnormal. TOPAMAX dosage: unknown. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Mar 20, 2007. Female patient, weighting 186.0 lb, was diagnosed with bipolar disorder and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: intra-abdominal haemorrhage, nephrolithiasis, post procedural complication, vascular injury. TOPAMAX dosage: 200 MG TWICE A DAY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Mar 13, 2007. Male patient, child 7 years of age, weighting 67.99 lb, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: eye pain, vision blurred. TOPAMAX dosage: unknown. During the same period patient was treated with TRILEPTAL. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2007. Female patient, 15 years of age, weighting 137.0 lb, was diagnosed with epilepsy, polycystic ovaries and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: depression, obsessive-compulsive disorder, social phobia. TOPAMAX dosage: unknown. During the same period patient was treated with METFORMIN. Patient recovered.

Consumer or non-health professional from BRAZIL reported TOPAMAX problem on Mar 13, 2007. Male patient, child 7 years of age, weighting 44.09 lb, was diagnosed with convulsion, gastrooesophageal reflux disease, gastric disorder, hypersensitivity and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, respiratory depression, somnolence. TOPAMAX dosage: unknown. During the same period patient was treated with MOTILIUM, DEPAKENE, BROMOPRIDE, OMEPRAZOLE, BEROTEC, ATROVENT, COD LIVER OIL. Patient recovered.

TOPAMAX problem was reported by a Health Professional from UNITED STATES on Mar 12, 2007. Female patient, weighting 227.0 lb, was diagnosed with headache, benign intracranial hypertension, multiple sclerosis, muscle spasms, pain, insomnia, depression and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, diarrhoea, electrocardiogram qt prolonged, heart rate irregular, hypokalaemia, metabolic acidosis, polyuria, weight decreased. TOPAMAX dosage: unknown. During the same period patient was treated with REBIF, BACLOFEN, IBUPROFEN, AMBIEN, LEXAPRO, DIAMOX. Patient recovered.

Health Professional from UNITED KINGDOM reported TOPAMAX problem on Mar 12, 2007. Male patient, 47 years of age, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: feeding disorder, speech disorder, weight decreased. TOPAMAX dosage: unknown. During the same period patient was treated with VALPROATE, LAMOTRIGINE. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Male patient, weighting 195.0 lb, was diagnosed with tremor, hypertension and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: corneal disorder, eye disorder, road traffic accident, vision blurred. TOPAMAX dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.

Health Professional from UNITED STATES reported TOPAMAX problem on Mar 15, 2007. Female patient, weighting 135.0 lb, was diagnosed with migraine prophylaxis, osteoporosis, nutritional support and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: angle closure glaucoma, cataract, headache, pupil fixed. TOPAMAX dosage: unknown. During the same period patient was treated with LISINOPRIL, BONIVA, VITAMINS, OMEGA. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2007. Female patient, 40 years of age, weighting 160.0 lb, was diagnosed with migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: paralysis. TOPAMAX dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported TOPAMAX problem on Mar 15, 2007. Female patient, weighting 236.0 lb, was diagnosed with bipolar disorder, hypothyroidism, depression, sleep disorder, anxiety and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: osteoarthritis. TOPAMAX dosage: unknown. During the same period patient was treated with SEROQUEL, SYNTHROID, EFFEXOR, XANAX. Patient was hospitalized. Patient recovered.

TOPAMAX problem was reported by a Physician from MEXICO on Mar 16, 2007. Male patient, child 10 years of age, weighting 44.09 lb, was diagnosed with epilepsy, convulsion and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: renal disorder. TOPAMAX dosage: unknown. During the same period patient was treated with TRILEPTAL, CLOBAZAM, DIPHENYLHYDANTOIN, CLONAZEPAM. Patient recovered.

Physician from GERMANY reported TOPAMAX problem on Mar 16, 2007. Female patient, weighting 119.0 lb, was diagnosed with migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: paraesthesia, restless legs syndrome. TOPAMAX dosage: unknown. Patient recovered.

TOPAMAX problem was reported by a Health Professional from GERMANY on Mar 16, 2007. Female patient, weighting 125.0 lb, was diagnosed with back pain and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, anxiety, burning sensation, dyspnoea, pharyngeal oedema, pruritus, swelling face. TOPAMAX dosage: unknown. During the same period patient was treated with ALEVE, ZOLOFT, ZOCOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Mar 27, 2007. Female patient, 41 years of age, weighting 265.0 lb, was diagnosed with weight control and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, cataract, feeling abnormal, feeling drunk, hypoaesthesia, insomnia, miosis, panic attack, pruritus. TOPAMAX dosage: 100MG TWICE DAILY PO. Patient was hospitalized. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Mar 27, 2007. Female patient, weighting 140.0 lb, was diagnosed with migraine and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: angle closure glaucoma, visual acuity reduced. TOPAMAX dosage: 50 MG PO. During the same period patient was treated with ZOLOFT. Patient recovered.

Physician from UNITED STATES reported TOPAMAX problem on Mar 26, 2007. Female patient, weighting 225.0 lb, was diagnosed with obesity and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: amnesia, cognitive disorder, confusional state, impaired work ability, mental disorder. TOPAMAX dosage: 50MG BID PO. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Male patient, weighting 330.0 lb, was diagnosed with pain, gastrooesophageal reflux disease, hypertension and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: cough, lung neoplasm malignant, weight decreased. TOPAMAX dosage: 25 MG TABLET TO 100 TABLET ORAL INITIATED 2005 AND DISCONTINUED 12-2006.. During the same period patient was treated with PREVACID, PROTONIX, LISINOPRIL. Patient died on 01/23/2007.

Physician from UNITED STATES reported TOPAMAX problem on Mar 28, 2007. Female patient, weighting 215.0 lb, was diagnosed with migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: heart rate irregular, palpitations, sinus tachycardia. TOPAMAX dosage: TITRATED UP TO 50 MG TWICE DAILY. Patient recovered.

TOPAMAX problem was reported by a Physician from GERMANY on Mar 27, 2007. Female patient, weighting 130.1 lb, was diagnosed with migraine and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: aldolase increased, blood creatine phosphokinase increased. TOPAMAX dosage: unknown. Patient recovered.

Pharmacist from UNITED KINGDOM reported TOPAMAX problem on Mar 27, 2007. Female patient, 14 years of age, was diagnosed with migraine and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood creatine phosphokinase increased. TOPAMAX dosage: unknown. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Mar 28, 2007. Female patient, 42 years of age, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased. TOPAMAX dosage: unknown. Patient died.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Mar 30, 2007. Female patient, weighting 130.0 lb, was diagnosed with migraine prophylaxis, pain prophylaxis, ulcer, osteopenia, arthritis, nutritional support and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: osteopenia. TOPAMAX dosage: unknown. During the same period patient was treated with TOPROL, NEXIUM, MIACALCIN, AMERGE, GLUCOSAMINE CHONDROITON, CALCIUM PLUS D, VITAMIN. Patient recovered.

TOPAMAX problem was reported by a Physician from GERMANY on Mar 30, 2007. Female patient, weighting 26.90 lb, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: cataract. TOPAMAX dosage: unknown. During the same period patient was treated with LAMICTAL. Patient recovered.

Physician from PORTUGAL reported TOPAMAX problem on Mar 30, 2007. Female patient, weighting 143.3 lb, was diagnosed with headache and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: retinal dystrophy, visual acuity reduced. TOPAMAX dosage: unknown. During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Mar 30, 2007. Female patient, weighting 155.0 lb, was diagnosed with migraine prophylaxis, osteoporosis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: back pain, nephrolithiasis, sepsis, urethral stenosis, urinary tract infection. TOPAMAX dosage: unknown. During the same period patient was treated with FOSAMAX, NASAL SPRAY. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported TOPAMAX problem on Apr 06, 2007. Female patient, 18 years of age, weighting 216.0 lb, was diagnosed with convulsion and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: pregnancy, premature rupture of membranes. TOPAMAX dosage: 200 MG TWICE DAILY BY MOUTH. Patient recovered.

TOPAMAX problem was reported by a Physician from AUSTRIA on Apr 05, 2007. Female patient, 26 years of age, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: lacrimation increased, visual acuity reduced. TOPAMAX dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported TOPAMAX problem on Apr 09, 2007. Female patient, weighting 135.0 lb, was diagnosed with migraine prophylaxis, osteoporosis, nutritional support, headache and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: angle closure glaucoma, cataract, depression, headache, pupil fixed. TOPAMAX dosage: unknown. During the same period patient was treated with LISINOPRIL, BONIVA, VITAMINS, OMEGA, RELPAX. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from ITALY on Apr 02, 2007. Male patient, 70 years of age, was diagnosed with essential tremor, hypertension, cardiac disorder, hypercholesterolaemia and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: asthenia, extrasystoles, malaise, tachycardia. TOPAMAX dosage: unknown. During the same period patient was treated with PRIMIDONE, AMIODORANE, FUROSEMIDE, SPIRONOLACTONE, ACETYLSALICYLIC ACID SRT, ATORVASTAINE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported TOPAMAX problem on Apr 05, 2007. Male patient, 30 years of age, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: memory impairment, sleep disorder, weight decreased. TOPAMAX dosage: unknown. During the same period patient was treated with CLONAZEPAM. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Female patient, weighting 158.0 lb, was diagnosed with muscle spasms, multiple sclerosis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dehydration, dysarthria, feeling hot, loss of consciousness, somnolence, vertigo, weight decreased. TOPAMAX dosage: unknown. During the same period patient was treated with REBIF. Patient recovered.

Physician from AUSTRIA reported TOPAMAX problem on Apr 06, 2007. Female patient, weighting 176.4 lb, was diagnosed with epilepsy, tachycardia paroxysmal, unevaluable event and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: lacrimation increased, maculopathy, visual acuity reduced. TOPAMAX dosage: unknown. During the same period patient was treated with ISOPTIN, FRISIUM, DEPAKENE RETARD, NEUROTOP RETARD. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Apr 06, 2007. Male patient, weighting 253.0 lb, was diagnosed with convulsion prophylaxis, anxiety and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: cardiac ventricular disorder, convulsion, hepatomegaly. TOPAMAX dosage: unknown. During the same period patient was treated with KLONOPIN, LEXAPRO. Patient died on 01/10/2007.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Apr 13, 2007. Female patient, 57 years of age, weighting 140.0 lb, was diagnosed with bipolar ii disorder, mood swings and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: asthenopia, eye disorder, eye pain, headache, vision blurred. TOPAMAX dosage: 50 MG 1/DAY PO. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Female patient, 29 years of age, was diagnosed with epilepsy, bipolar i disorder, bipolar disorder and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: dehydration, dry eye, dysphagia, tremor. TOPAMAX dosage: unknown. During the same period patient was treated with LEXAPRO, SEROQUEL, KLONOPIN, DEPAKOTE. Patient recovered.

Consumer or non-health professional from BRAZIL reported TOPAMAX problem on Apr 09, 2007. Female patient, 53 years of age, weighting 108.0 lb, was diagnosed with depression, hypothyroidism and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, chest pain, tachycardia, weight decreased. TOPAMAX dosage: unknown. During the same period patient was treated with RIVOTRIL, SYNTHROID. Patient recovered.

TOPAMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Male patient, weighting 156.0 lb, was diagnosed with pain and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: back pain, belligerence, feeling of despair, hostility, suicidal ideation. TOPAMAX dosage: 25 MG 1 DAYLY PO. Patient recovered.

Physician from UNITED STATES reported TOPAMAX problem on Apr 26, 2007. Male patient, child 11 years of age, was diagnosed with epilepsy and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: accidental overdose, hypothermia, lethargy. TOPAMAX dosage: (2-15 MG CAPSULES AM AND 3- 15 MG CAPSULES PM),. During the same period patient was treated with ZANAFLEX, KLONIPIN. Patient was hospitalized. Patient recovered.

TOPAMAX problem was reported by a Physician from UNITED STATES on Apr 18, 2007. Female patient, 53 years of age, was diagnosed with migraine prophylaxis and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: osteoporosis, resorption bone increased. TOPAMAX dosage: unknown. During the same period patient was treated with IMITREX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TOPAMAX problem on Apr 27, 2007. Female patient, 47 years of age, weighting 170.0 lb, was diagnosed with headache and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: fatigue, hypothalamo-pituitary disorder, weight increased. TOPAMAX dosage: 100MG PER DAY 75MG PER DAY. Patient recovered.

Showing 1-75 of 754 Next >

Ask Our Patient Community about TOPAMAX

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
Perindopril